Clayton Jacobs

Mostly professional account Follower of all things dementia, nonprofit leadership, public health, fundraising & the like.
ED of @alzgpa but views here=own

[Alzheimer's Association @alzassociation]

Just announced: We are launching a new funding program that will broaden our global collaboration with partners and scientific leaders across the globe.

Learn more about our Global Real-World Data Platforms Program: https://t.co/JHZIe06em0

#DefeatingDementia @WorldDementia

[Clayton Jacobs @PaClayALZ]

@TharickAPascoal @AlzGPA @LabPascoal @Pamlukasewicz @BellaverBruna @firoza_lussier @gbnegrini @SarahAbbas52 @SaraEMurphy @BrittanyGrego Love this! Thank you for all you do

[ALZ Pennsylvania @ALZPennsylvania]

This is why @MikeyHoodKDKA of @PGHTodayLive walks to end Alzheimer's. Will you join us this year? Visit https://t.co/4uqRKBpGGs to find a Walk near you. #Walk2EndALZ

[ALZ Impact Movement @ALZIMPACT]

We’re proud to celebrate @HealthAllegheny for receiving the BOLD public health program award! @SenBobCasey’s leadership in cosponsoring the #BOLDAlzheimersAct helped make this possible.

[ALZ Impact Movement @ALZIMPACT]

Retweet if you stand with people living with Alzheimer’s who want #AccessNow to FDA-approved treatments! @CMSGov needs to hear from you. #OpeningDay

[Alzheimer's Association @alzassociation]

“We're in a caregiving crisis...One path forward is more investment in home & community-based services…We [also] need to ensure we're investing in oversight centered on long-term care facilities.” Thank you, @SenBobCasey for emphasizing the importance of quality long-term care.

[Michael Reich @mwreich]

.@SecBecerra, if @CMSGov will treat drugs for all diseases the same, can you start now? 2,000 people living w/ Alzheimer's each day progress beyond the point where current treatments will help. Yet, still you block Medicare coverage when you don't do so for any other disease.

[Kanada Yazbek @lifewithmci]

I heard a lot of inaccuracies of information yesterday as we listened to testimony from @SecBecerra. @GOPMajorityWhip, We need your help. I deserve #moretime as do the other 6 million Americans living with Alzheimer’s. #ENDALZ #mnleg

[Bruna Bellaver @BellaverBruna]

Proud to share our recent work demonstrating the distinct astrocyte responses to amyloid and tau. Thank @erzimmer, @zimmerneurolab, @LabPascoal and all collaborators!

[Clayton Jacobs @PaClayALZ]

@RepPattyKim Congratulations and looking forward to working with you!

[Alzheimer's Association @alzassociation]

Each day that @CMSGov refuses to cover the new FDA-approved treatment, 2,000 people lose the chance for #MoreTime with their loved ones. We will not back down in fighting for equitable access. https://t.co/WPJZ7TZ2UF

[ALZ Impact Movement @ALZIMPACT]

🎉IT’S OFFICIAL!🎉Key provisions of the #ENACTAct, language to strengthen the @US_FDA accelerated approval pathway, a $226 million increase in Alzheimer’s & dementia research funding at @NIH, and $33 million to fund the #BOLDAlzheimersAct have been signed into law. (1/2)

[Clayton Jacobs @PaClayALZ]

@TOsborne622 @AARPPA Congratulations and such an impactful voice to be a part of these discussions

[TODAY @TODAYshow]

On #SundayTODAY: @Maggie_Vespa has this week’s #SundayFocus on news of a promising new drug found to reduce cognitive decline in Alzheimer's patients significantly, offering a potential breakthrough in the long fight against the devastating disease.
https://t.co/4HB8O5l7QX

[Michael Reich @mwreich]

Meaningfully change the course of Alzheimer's Disease? Yep, this is a real turning point. People in the early stages of the disease will have more quality time with family and friends, but only if @US_FDA approves this new drug and @CMSGov allows coverage. Our work is not done.

[Clayton Jacobs @PaClayALZ]

Such important news for people facing early-stage Alzheimer's Disease who need treatments so they have more time with their families and doing the things they enjoy most. #endalz @alzassociation

[Alzheimer's Association @alzassociation]

We are further encouraged by the Phase 3 data presented today from the CLARITY AD global clinical trial of lecanemab. Read our full statement: https://t.co/4WCKHMr56d

[Joanne Pike, DrPH @joannepikedrph]

I’m honored to become the next CEO of @alzassociation. As the leader in Alzheimer's care, support and research, the Alzheimer’s Association shares my values of putting people and communities first and delivering excellence with integrity and inclusiveness. #ENDALZ

[Clayton Jacobs @PaClayALZ]

Facing #Alzheimer’s is tough enough already. Tear down Medicare’s barrier to FDA-approved Alzheimer's treatments, @CMSGov. Help us #ENDALZ #progess https://t.co/JTYOurKc8c

[Alzheimer's Association @alzassociation]

On behalf of the more than 6 million Americans living with Alzheimer’s and their families, we enthusiastically welcome the positive topline data reported today on the CLARITY AD Phase 3 clinical trial of lecanemab. Read our full statement: https://t.co/PV7bz21FXv. #Progress (1/4)

[PittsburghTodayLive @PGHTodayLive]

ALZHEIMER’S AWARENESS: A local mother shares her story of living with Alzheimer's. Learn more about how you can help support and raise awareness this October at the @alzassociation Alzheimer’s Walk. #sponsored #ENDALZ https://t.co/N0pppICuQg